Advertisement
Ambulation disability carries greatest risk, most disease-modifying therapies aren’t implicated
Emerging technology can quantify multiple properties of brain tissue in a single scan
Clinical cohort study helps define red flags for these rare MS mimics
Survey suggests need for education about FDA’s mission, trustworthiness
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cannabinoid oromucosal spray is poised for FDA submission in 2021
Panel outlines research priorities around a promising alternative to imaging markers
Get ready for central vein sign and optical coherence tomography
Depressed patients also have increased odds for new brain lesions on MRI
Research still needed for many unknowns
Researchers hope it will lead to earlier, more accurate diagnosis
Advertisement
Advertisement